ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2161

Biopsychosocial Typologies of Pain in a Cohort of Patients With Systemic Sclerosis

Erin L. Merz1, Vanessa L. Malcarne1, Shervin Assassi2, Deepthi Nair2, Tiffany Graham2, Brayden Yellman2, Rosa M. Estrada-Y-Martin3 and Maureen D. Mayes2, 1SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 3Pulmonary and Critical Care Medicine, University of Texas Health Science Center at Houston, Houston, TX

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: pain, Psychosocial factors and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: ARHP Osteoarthritis - Clinical Aspects: Psychology/Social Sciences

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Despite being a common problem in Systemic Sclerosis, the extant literature on pain has primarily focused on biomedical correlates, or bivariate relationships with a few psychological characteristics. There is a need to investigate the more heuristic biopsychosocial model, which incorporates the simultaneous contributions of medical, psychological, and social variables in understanding pain.

Methods: Patients with Systemic Sclerosis (N = 333) received clinical exams and completed self-report surveys at enrollment to the Genetics versus ENvironment In Scleroderma Outcome Study. Latent profile analysis was used to derive biopsychosocial profiles of patients using clinical indicators of disease severity (modified Rodnan skin score, percent predicted forced vital lung capacity), perceived physical health, health worry, mental health, and social support. The resultant profiles were examined in relation to pain and pain medication usage.

Results: A 3-profile solution provided the best fit to the data. Based on the biopsychosocial indicators, the profiles were characterized as Managing (n = 217), Resilient (n = 86), and Distressed (n = 30). Both the Managing and Distressed groups had relatively less severe skin thickening and percent predicted forced vital lung capacity, but the Distressed group reported much poorer perceived physical health, mental health, and social support. The Resilient group had a much more severe disease manifestation; however, Resilient patients mirrored the Managing group with relatively better psychosocial functioning. Between-group differences for pain emerged, with the Distressed group, whose disease was less severe than the Resilient group, reporting the highest pain and the greatest utilization of acetaminophen/non-steroidal anti-inflammatory drugs, tramadol, and narcotic pain medication.

Conclusion: Clinicians should consider biopsychosocial characteristics as contributing factors to the experience of pain in patients with Systemic Sclerosis. Although disease severity is a risk factor for pain, psychological and social characteristics are also important in understanding disease-related pain. Patients with characteristics similar to those in the Distressed profile may be at an increased risk for pain and would likely benefit from a referral to a behavioral health or other ancillary service providers for an adjunct treatment for pain management, rather than relying solely on pharmacological therapies.


Disclosure:

E. L. Merz,
None;

V. L. Malcarne,
None;

S. Assassi,
None;

D. Nair,
None;

T. Graham,
None;

B. Yellman,
None;

R. M. Estrada-Y-Martin,
None;

M. D. Mayes,

Actelion Pharmaceuticals US,

2,

Roche Pharmaceuticals,

2,

Celgene,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/biopsychosocial-typologies-of-pain-in-a-cohort-of-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology